Distribution of factor VIII mRNA and antigen in human liver and other tissues.
about
Human lecithin-cholesterol acyltransferase gene: complete gene sequence and sites of expressionProgress and challenges in the development of a cell-based therapy for hemophilia AGene therapy for hemophiliaIn search of the eighth factor: a personal reminiscenceSecretion of coagulant factor VIII activity and antigen by in vitro cultivated rat liver sinusoidal endothelial cellsEndogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia ADelivery of factor VIII gene into skeletal muscle cells using lentiviral vector.Interaction of incontinentia pigmenti and factor VIII mutations in a female with biased X inactivation, resulting in haemophiliaMurine coagulation factor VIII is synthesized in endothelial cells.A conditional knockout mouse model reveals endothelial cells as the principal and possibly exclusive source of plasma factor VIII.New insights into the coagulopathy of liver disease and liver transplantationComparison of factor IX methylation on human active and inactive X chromosomes: implications for X inactivation and transcription of tissue-specific genes.A monoclonal antibody to von Willebrand factor (vWF) inhibits factor VIII binding. Localization of its antigenic determinant to a nonadecapeptide at the amino terminus of the mature vWF polypeptide.Factor VIII A3 domain substitution N1922S results in hemophilia A due to domain-specific misfolding and hyposecretion of functional proteinIn vivo production of human factor VII in mice after intrasplenic implantation of primary fibroblasts transfected by receptor-mediated, adenovirus-augmented gene delivery.Factor VIII Is Synthesized in Human Endothelial Cells, Packaged in Weibel-Palade Bodies and Secreted Bound to ULVWF Strings.DNA replication analysis of FMR1, XIST, and factor 8C loci by FISH shows nontranscribed X-linked genes replicate lateRole of bone marrow transplantation for correcting hemophilia A in mice.Genetic induction of immune tolerance to human clotting factor VIII in a mouse model for hemophilia ARat hepatocytes in serum-free primary culture elaborate an extensive extracellular matrix containing fibrin and fibronectinIdentification of a novel high molecular weight protein preferentially expressed by sinusoidal endothelial cells in normal human tissues.Hepatocyte tissue factor activates the coagulation cascade in miceShort-term correction of factor VIII deficiency in a murine model of hemophilia A after delivery of adenovirus murine factor VIII in utero.Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in Chinese hamster ovary cells.The liver sinusoidal endothelial cell: a cell type of controversial and confusing identity.Intracellular trafficking of factor VIII to von Willebrand factor storage granules.Mesenchymal stem cells contribute to endogenous FVIII:c production.Mutations and a polymorphism in the factor VIII gene discovered by denaturing gradient gel electrophoresisFactor VIII therapy for hemophilia A: current and future issues.A 110-amino acid region within the A1-domain of coagulation factor VIII inhibits secretion from mammalian cells.Roles of phytanoyl-CoA alpha-hydroxylase in mediating the expression of human coagulation factor VIII.Differential interaction of coagulation factor VIII and factor V with protein chaperones calnexin and calreticulin.Role of the liver-enriched transcription factor hepatocyte nuclear factor 1 in transcriptional regulation of the factor V111 gene.Characterization of four novel molecular changes in the promoter region of the factor VIII gene.Haemostatic problems in liver disease.A novel missense mutation in the factor VIII gene identified by analysis of amplified hemophilia DNA sequencesClinical efficacy and recovery levels of recombinant FVIIa (NovoSeven) in the treatment of intracranial haemorrhage in severe neonatal FVII deficiency.Liver transplantation in hemophilia AA monoclonal antibody (NMC-VIII/10) to factor VIII light chain recognizing Glu1675-Glu1684 inhibits factor VIII binding to endogenous von Willebrand factor in human umbilical vein endothelial cells.Early events in kidney donation: progression of endothelial activation, oxidative stress and tubular injury after brain death.
P2860
Q24609462-09D63E6D-E679-40D3-85E4-66D2050C8C37Q27027298-9F209ABC-35C8-462D-AAF4-8983ED626A33Q28081911-7C6688E4-3A01-4961-9E5A-555F1BE0E13EQ28188221-D876A62B-F2DB-47EA-98A8-67FE787518E1Q28573650-9BE97751-73F5-4032-A244-F59E37CDFD36Q30585975-8E83184A-BA55-4CB6-B581-DD3C0DBAE713Q33565275-D30E856D-FFAB-46A9-9C2B-55A349D49458Q33595466-D627F332-3467-4271-94A2-C751FFD76BE1Q33749623-372F7031-7ECB-4370-A591-1E5648928706Q33749629-43396DCB-A1D5-4958-9D8C-827D7A0EC686Q33866656-FDFB6573-028C-4193-9B99-32C59CC343C1Q33880345-C9309EA8-0375-4A07-B860-14173CB07B3AQ34576333-9D9787F7-A9B9-4607-B461-5D0B07F7DABCQ34707266-FA22AE63-39EE-4A3F-A3D6-CF8FCF7104F3Q35387018-A1DB0FCA-A789-49F8-8D2D-642D9B3B8DE6Q35810108-7275FC9B-F14C-4C1C-9969-545FE0E18C7CQ35889273-D4E7AE0F-FA64-443C-9ACC-CB9EE7D09F47Q36015228-E89D2126-677F-4A42-91A1-9A1447273F60Q36097677-7977D6AE-52E8-43D5-882C-22586A9ED08EQ36217755-31FF800C-BF82-4979-83C6-FC2575F5C1D8Q36529914-FC24816E-02BB-46A6-9077-08C933439846Q36666812-99B56C04-0B56-4B89-9153-92D0BA34A7BCQ36672047-FD5B2F38-965F-468A-9D13-E01205FA175BQ36768042-507D788C-9E83-43B4-873A-D88649B80060Q37026499-601FD36E-8636-452D-9F7B-EF9D687FDA30Q37377963-FE98A347-B17A-48F1-8411-981A8F4EFCA5Q37637891-47768C8F-638C-4F55-AE8B-8DE52738FDA2Q37717801-5CAD3525-932F-411A-BC81-171F3F74A146Q38203350-AAA7C0ED-A63B-4164-AF91-AA8EDFD09B8BQ38296274-41BBE8B6-B4A1-4669-9227-A423F9FC77A2Q38296475-6165D4A5-9145-4825-99EA-3CFB403E2B90Q38337996-BE5FD24C-AFBC-46A1-8EC2-FCB2E64C232EQ38358525-C9088802-07B5-4622-A72C-15E22A831F7FQ39039126-F6014985-4200-4314-8EDF-5C96A0C90C18Q39588573-FC6D615B-5B78-41A8-B638-C8B99B07E1CBQ40392004-33832960-5A2A-4E91-B56D-5EA7B37B98F5Q41713849-DA90867F-D1D1-4A6A-8E1F-DB064660C7EDQ41983566-3F0883A0-2F9A-4333-B218-5E655EBE89D1Q43405759-E4314BF0-90C3-44EA-B62A-2F9FF47C570CQ44641015-88458249-F885-438C-B23D-CD51D27B27F7
P2860
Distribution of factor VIII mRNA and antigen in human liver and other tissues.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh-hant
name
Distribution of factor VIII mRNA and antigen in human liver and other tissues.
@en
Distribution of factor VIII mRNA and antigen in human liver and other tissues.
@nl
type
label
Distribution of factor VIII mRNA and antigen in human liver and other tissues.
@en
Distribution of factor VIII mRNA and antigen in human liver and other tissues.
@nl
prefLabel
Distribution of factor VIII mRNA and antigen in human liver and other tissues.
@en
Distribution of factor VIII mRNA and antigen in human liver and other tissues.
@nl
P2093
P356
P1433
P1476
Distribution of factor VIII mRNA and antigen in human liver and other tissues.
@en
P2093
P2888
P304
P356
10.1038/317726A0
P407
P577
1985-10-01T00:00:00Z
P5875
P6179
1014534835